IL1B and neoplasm: An interesting study using “triple-null” mice lacking IL-1 and TNFα receptors was performed in Chris Bradfield’s laboratory and demonstrated the important role of IL-1β mediating TCDD’s toxic effects such as liver inflammation and tumor promoting effects [33,34].